Showing 12,021 - 12,040 results of 23,778 for search '(( 5 ((wt decrease) OR (nn decrease)) ) OR ( 100 ((mean decrease) OR (a decrease)) ))', query time: 1.00s Refine Results
  1. 12021

    Mutually exclusive expression of Flag-Dmp1 and Ki67 in <i>MDTG;neu</i> tumors. by Elizabeth A. Fry (477763)

    Published 2013
    “…<p>A. Total tumor weight harvested at sacrifice. The amount of tumors recovered at sacrifice (4 weeks after the first tumor was found) was significantly decreased in all three transgenic strains. …”
  2. 12022
  3. 12023

    Bone marrow and peripheral blood and bone marrow white blood cells (WBC) count and FACS analysis, experiment 2. by Valentina A. Carozzi (458128)

    Published 2013
    “…The number of hematopoietic cells in the peripheral blood expressing the pan-leukocyte antigen CD45 is also reported (C). A comparable immune-suppression was observed in both X-Ray and X-Ray-bortezomib-treated animals after the irradiation induction and maintenance doses, as shown by the decreased cellularity and leukopenia in the BM and spleen of irradiated mice, regardless of bortezomib treatment.…”
  4. 12024

    Comprehensive Evaluation and Implementation of Improvement Actions in Butcher Shops by Gerardo A. Leotta (3115335)

    Published 2016
    “…A comprehensive evaluation was made and risk was quantified on a 1–100 scale as high-risk (1–40), moderate-risk (41–70) or low-risk (71–100). …”
  5. 12025

    DataSheet_1_Leveraging intelligent optimization for automated, cardiac-sparing accelerated partial breast treatment planning.xlsx by Joel A. Pogue (14597114)

    Published 2023
    “…Physicist-selected plans were deemed clinically acceptable without modification for 75% and 90% of plans by physicians A and B, respectively. Physicians A and B scored at least one automatically generated plan as clinically acceptable for 100% and 95% of planning intents, respectively.…”
  6. 12026

    Table_1_Leveraging intelligent optimization for automated, cardiac-sparing accelerated partial breast treatment planning.docx by Joel A. Pogue (14597114)

    Published 2023
    “…Physicist-selected plans were deemed clinically acceptable without modification for 75% and 90% of plans by physicians A and B, respectively. Physicians A and B scored at least one automatically generated plan as clinically acceptable for 100% and 95% of planning intents, respectively.…”
  7. 12027

    Table_1_Global, regional, and national HIV/AIDS disease burden levels and trends in 1990–2019: A systematic analysis for the global burden of disease 2019 study.docx by Xuebin Tian (7402760)

    Published 2023
    “…Background<p>Since the first HIV/AIDS case appeared in 1980s, HIV/AIDS has been the focus of international attention. As a major public health problem, there are epidemiological uncertainties about the future of HIV/AIDS. …”
  8. 12028

    Effect of Go-6976 on S6 Kinase activity. by Katherine A. Robinson (645068)

    Published 2014
    “…<p>Adipocytes were preincubated for 18 h in 5 mM glucose (IS) or in 25 mM glucose+0.6 nM insulin (GI-IR). <b>A.</b> Acute insulin treatment (100 nM for 15 min) stimulated activating phosphorylation of S-6 kinase (8–10-fold) and of its substrate S-6 ribosomal protein (4–5-fold). …”
  9. 12029

    Image_1_Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study.tif by Xiaofeng Chen (392939)

    Published 2022
    “…Grade 3 TRAEs occurred in 8 (40.0%) patients, the most common being decreased platelet count (10.0%) and increased γ-glutamyl transferase (10.0%). …”
  10. 12030

    Image_2_Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study.tif by Xiaofeng Chen (392939)

    Published 2022
    “…Grade 3 TRAEs occurred in 8 (40.0%) patients, the most common being decreased platelet count (10.0%) and increased γ-glutamyl transferase (10.0%). …”
  11. 12031

    Table_1_Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study.docx by Xiaofeng Chen (392939)

    Published 2022
    “…Grade 3 TRAEs occurred in 8 (40.0%) patients, the most common being decreased platelet count (10.0%) and increased γ-glutamyl transferase (10.0%). …”
  12. 12032

    Inverted brightfield images of mock- and HSV-1-infected neurons. by Colleen A. Mangold (10344932)

    Published 2021
    “…<p>Different HSV-1 strains are depicted in columns, and 12 vs 24 hpi in rows. Images from <b><a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1009441#ppat.1009441.g005" target="_blank">Fig 5A</a></b> were inverted and brightness and contrast were equally adjusted to better visualize changes in neurite adhesion and fasciculation following infection. …”
  13. 12033

    Predictions of the Brownian zipper model. by Emmet A. Francis (13450211)

    Published 2022
    “…<p>(A) A model cell spreading on the highest tested ligand density (100%) quickly approaches a spherical cap morphology. …”
  14. 12034

    Correlation analyses between studied genes. by Marwa A. Ali (11973086)

    Published 2024
    “…ROC curve analysis revealed that sensitivity and specificity tests for <i>NEAT-1</i> and IL-6 levels in the diagnosis of cases illustrated a sensitivity of (100% and 97.9%) and a specificity of (85% and 100%) at cut-off values (0.985 and 12.55), respectively. …”
  15. 12035

    Data Sheet 1_Endophytic and antagonistic Bacillus amyloliquefaciens 8SE-IF1-derived nanoparticles encumber phytopathogenic oomycetes, fungi, bacteria, and viruses with enhanced gro... by A. Mary Sharmila (21898730)

    Published 2025
    “…<p>Green synthesis of nanoparticles (Gs-NPs) of antimicrobial compounds from endophytic and antagonistic microbes is a novel strategy for managing plant diseases caused by different pathogens. …”
  16. 12036

    Primers used in q-PCR. by Marwa A. Ali (11973086)

    Published 2024
    “…ROC curve analysis revealed that sensitivity and specificity tests for <i>NEAT-1</i> and IL-6 levels in the diagnosis of cases illustrated a sensitivity of (100% and 97.9%) and a specificity of (85% and 100%) at cut-off values (0.985 and 12.55), respectively. …”
  17. 12037

    Double immunofluorescent labelling for actin and phosphorylated p44/42 (a) from lumbar DRGs of control, untreated STZ-induced diabetic, and insulin-treated STZ-induced diabetic rat... by Kazuhiro Sugimoto (452376)

    Published 2013
    “…<p>Intensities of actin (b) and phosphorylated p44/42 fluorescence (c) are displayed as a scatter plot against neuronal area. The mean pixel intensities of actin (d) in sensory neurons and satellite cells are unchanged among the three groups. …”
  18. 12038

    Inhibition of protease activity of <i>S</i>. <i>marcescens</i> by sitagliptin. by Hisham A. Abbas (8720742)

    Published 2020
    “…<p>A) <i>S</i>. <i>marcescens</i> overnight cultures in LB broth in the presence and absence of sitagliptin sub-MIC were adjusted to OD<sub>600</sub> 0.4, centrifuged at 10,000 rpm for 15 min and the protease activities were measured by adding the supernatants in 100 μl aliquots to the wells made in skim milk agar plates (5%). …”
  19. 12039

    Uric acid negatively regulates AMPK activity. by Miguel A. Lanaspa (119910)

    Published 2012
    “…B) Uric acid further increases fructose-induced triglyceride accumulation (top) and decreases β- hydroxybutyrate levels (bottom) in a dose-dependent manner while allopurinol blocks it. …”
  20. 12040

    Generation of beating cell colonies of EC P19 cells after induction with different OT forms. by Bogdan A. Danalache (360410)

    Published 2013
    “…<p>Micrographs (100× magnification) show cultures at day 10 with dotted lines encircling beating colonies and induced by: (<b>A</b>) Non-inducer, (<b>B</b>) OT, (<b>C</b>) OT-G, (<b>D</b>) OT-GK, (<b>E</b>) OT-GKR. …”